Variability in the management recommendations given for high-risk breast lesions detected on image-guided core needle biopsy at US academic institutions

E Falomo, C Adejumo, KA Carson, S Harvey… - Current Problems in …, 2019 - Elsevier
The purpose of this study was to describe and compare the management recommendations
provided in the setting of a high-risk lesion diagnosed on core needle biopsy of the breast at …

[HTML][HTML] Atypical ductal hyperplasia after vacuum-assisted breast biopsy: can we reduce the upgrade to breast cancer to an acceptable rate?

L Nicosia, A Latronico, F Addante, R De Santis… - Diagnostics, 2021 - mdpi.com
(1) Background: to evaluate which factors can reduce the upgrade rate of atypical ductal
hyperplasia (ADH) to in situ or invasive carcinoma in patients who underwent vacuum …

Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41

RJ Hooley, KL Greenberg, RM Stackhouse, JL Geisel… - Radiology, 2012 - pubs.rsna.org
Purpose To determine performance and utilization of screening breast ultrasonography (US)
in women with dense breast tissue who underwent additional screening breast US in the 1st …

[HTML][HTML] Reducing false-positive biopsies: a pilot study to reduce benign biopsy rates for BI-RADS 4A/B assessments through testing risk stratification and new …

CI Flowers, C O'Donoghue, D Moore, A Goss… - Breast cancer research …, 2013 - Springer
The aim of this study is to evaluate Breast Imaging Reporting and Data Systems (BI-RADS)
4A/B subcategory risk estimates for ductal carcinoma in situ (DCIS) and invasive cancer (IC) …

Clinical management of atypical ductal hyperplasia on vacuum-assisted biopsy of microcalcifications: external validation study of a decision tree selecting patients …

I El Sanharawi, G Bataillon, G Journo… - European Journal of …, 2021 - Elsevier
Background Atypical lesions found on percutaneous breast biopsy raise specific
management issues. The aim of this study was to validate the previous performance of a …

A model to predict the risk of upgrade to malignancy at surgery in atypical breast lesions discovered on percutaneous biopsy specimens

C Uzan, C Mazouni, M Ferchiou, L Ciolovan… - Annals of surgical …, 2013 - Springer
Background When any atypical feature is identified on a percutaneous biopsy specimen of a
suspicious breast lesion, surgical excision is mandatory, leading to unnecessary surgeries …

Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum‐assisted, intact‐specimen breast biopsy device

A Sie, DC Bryan, V Gaines, LK Killebrew… - … Journal of the …, 2006 - Wiley Online Library
Abstract BACKGROUND. Percutaneous, vacuum‐assisted, large‐gauge core needle biopsy
(VACNB) provides an alternative to open surgical biopsy as an initial diagnostic tool for …

Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade

KH Allison, PR Eby, J Kohr, WB DeMartini, CD Lehman - Human pathology, 2011 - Elsevier
We evaluated 97 cases of review-confirmed atypical ductal hyperplasia found on
stereotactic vacuum-assisted breast biopsy of suspicious calcifications. The number and …

Contemporary indications for diagnostic open biopsy in women assessed for screen-detected breast lesions: a ten-year, single institution series of 814 consecutive …

G Farshid, PG Gill - Breast cancer research and treatment, 2017 - Springer
Purpose In contemporary practice, 5% of women with non-malignant needle biopsies of
screen-detected lesions still require diagnostic open biopsy (OBx). Our aims are to (i) …

Predictors of Underestimation of Malignancy after Image‐Guided Core Needle Biopsy Diagnosis of Flat Epithelial Atypia or Atypical Ductal Hyperplasia

CC Yu, SH Ueng, YC Cheung, SC Shen… - The breast …, 2015 - Wiley Online Library
Flat epithelial atypia (FEA) and atypical ductal hyperplasia (ADH) are precursors of breast
malignancy. Management of FEA or ADH after image‐guided core needle biopsy (CNB) …